$OMQS
OMNIQ Corp.

2024 Q2 Form 10-Q Financial Statement

#000149315224019872 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $19.06M $18.32M
YoY Change -6.79% -34.16%
Cost Of Revenue $14.17M $13.26M
YoY Change -14.41% -40.0%
Gross Profit $4.883M $5.058M
YoY Change 25.66% -11.6%
Gross Profit Margin 25.62% 27.61%
Selling, General & Admin $5.025M $5.565M
YoY Change -5.46% -17.75%
% of Gross Profit 102.91% 110.02%
Research & Development $462.0K $405.0K
YoY Change -17.35% -4.26%
% of Gross Profit 9.46% 8.01%
Depreciation & Amortization $92.00K $116.0K
YoY Change -4.17% 7.41%
% of Gross Profit 1.88% 2.29%
Operating Expenses $5.806M $6.317M
YoY Change -9.17% -18.31%
Operating Profit -$923.0K -$1.259M
YoY Change -63.17% -37.39%
Interest Expense $917.0K
YoY Change -2.24%
% of Operating Profit
Other Income/Expense, Net -$2.122M -$886.0K
YoY Change 45.24% -47.54%
Pretax Income -$3.045M -$2.145M
YoY Change -23.24% -42.03%
Income Tax -$47.00K
% Of Pretax Income
Net Earnings -$3.045M -$2.098M
YoY Change -21.24% -40.18%
Net Earnings / Revenue -15.98% -11.45%
Basic Earnings Per Share -$0.28 -$0.20
Diluted Earnings Per Share -$0.20
COMMON SHARES
Basic Shares Outstanding 10.69M shares 10.69M shares
Diluted Shares Outstanding 10.69M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $881.0K
YoY Change -72.72%
Cash & Equivalents $1.373M $881.0K
Short-Term Investments
Other Short-Term Assets $42.00K $319.0K
YoY Change -88.68% -56.24%
Inventory $5.787M $5.676M
Prepaid Expenses $1.240M $806.0K
Receivables $21.93M $18.43M
Other Receivables $0.00
Total Short-Term Assets $30.38M $26.11M
YoY Change 6.22% -34.93%
LONG-TERM ASSETS
Property, Plant & Equipment $898.0K $981.0K
YoY Change -34.6% -27.92%
Goodwill $2.831M $2.891M
YoY Change -82.77% -82.46%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.043M $1.965M
YoY Change 69.97% 21.3%
Total Long-Term Assets $12.24M $12.75M
YoY Change -54.95% -55.02%
TOTAL ASSETS
Total Short-Term Assets $30.38M $26.11M
Total Long-Term Assets $12.24M $12.75M
Total Assets $42.62M $38.86M
YoY Change -23.58% -43.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $57.15M
YoY Change -1.84%
Accrued Expenses $3.069M
YoY Change -12.99%
Deferred Revenue
YoY Change
Short-Term Debt $391.0K
YoY Change -92.52%
Long-Term Debt Due $9.451M
YoY Change -14.38%
Total Short-Term Liabilities $78.58M $72.49M
YoY Change 14.14% -9.1%
LONG-TERM LIABILITIES
Long-Term Debt $1.392M
YoY Change 3063.64%
Other Long-Term Liabilities $525.0K $619.0K
YoY Change 194.94% 97.13%
Total Long-Term Liabilities $525.0K $619.0K
YoY Change 194.94% 97.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $78.58M $72.49M
Total Long-Term Liabilities $525.0K $619.0K
Total Liabilities $80.97M $75.39M
YoY Change 12.97% -7.28%
SHAREHOLDERS EQUITY
Retained Earnings -$119.0M -$116.0M
YoY Change 29.35% 31.82%
Common Stock $11.00K $11.00K
YoY Change 37.5% 37.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$38.36M -$36.53M
YoY Change
Total Liabilities & Shareholders Equity $42.62M $38.86M
YoY Change -23.58% -43.24%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$3.045M -$2.098M
YoY Change -21.24% -40.18%
Depreciation, Depletion And Amortization $92.00K $116.0K
YoY Change -4.17% 7.41%
Cash From Operating Activities -$623.0K
YoY Change -51.67%
INVESTING ACTIVITIES
Capital Expenditures $48.00K
YoY Change -85.92%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$48.00K
YoY Change -85.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$971.0K
YoY Change -132.37%
NET CHANGE
Cash From Operating Activities -$623.0K
Cash From Investing Activities -$48.00K
Cash From Financing Activities -$971.0K
Net Change In Cash -$1.642M
YoY Change -219.85%
FREE CASH FLOW
Cash From Operating Activities -$623.0K
Capital Expenditures $48.00K
Free Cash Flow -$671.0K
YoY Change -58.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2024Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2024Q1 OMQS Increase Decrease In Accounts Payable And Accrued Liabilities Related Party
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
usd
CY2024Q1 OMQS Proceeds From Exercises Of Options And Warrants
ProceedsFromExercisesOfOptionsAndWarrants
usd
CY2023Q1 OMQS Net Assets Acquired In Business Combination
NetAssetsAcquiredInBusinessCombination
usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10692891 shares
CY2024Q1 us-gaap Other Assets
OtherAssets
1965000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
1758000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13259000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22099000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
5058000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
5722000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
405000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
423000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5565000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6766000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
116000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
108000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
231000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
436000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
6317000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
7733000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1259000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2011000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
917000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
938000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-751000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-886000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1689000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2145000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3700000 usd
CY2024Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-47000 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-193000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-47000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-193000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2098000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3507000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
241000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
457000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1857000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3050000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2098000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3507000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
8000 usd
CY2024Q1 OMQS Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-2105000 usd
CY2023Q1 OMQS Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-3515000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10688340 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10688340 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7749870 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7749870 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10526000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
8000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
10000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
516000 usd
CY2023Q1 OMQS Stock Issued During Period Value Exercise Of Stock Options And Warrants
StockIssuedDuringPeriodValueExerciseOfStockOptionsAndWarrants
173000 usd
CY2023Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
457000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3507000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-12840000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-35020000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-35020000 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
7000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
293000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
56000 usd
CY2024Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
241000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2098000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-36529000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-36529000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2098000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3507000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
293000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
516000 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
45000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
347000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
544000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
299000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
281000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
508000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2228000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-181000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
384000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-640000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
395000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-242000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-104000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
696000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3954000 usd
CY2023Q1 OMQS Increase Decrease In Accounts Payable And Accrued Liabilities Related Party
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
1000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
795000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
91000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-302000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-282000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
719000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
37000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-489000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
8000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-623000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1289000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
341000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-341000 usd
CY2024Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
6000 usd
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
10000 usd
CY2023Q1 OMQS Proceeds From Exercises Of Options And Warrants
ProceedsFromExercisesOfOptionsAndWarrants
173000 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1133000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
544000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
156000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3361000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-971000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1642000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1370000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
845000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
549000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1678000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1311000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
881000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3230000 usd
CY2024Q1 OMQS Declared Dividends Payable
DeclaredDividendsPayable
7000 usd
CY2023Q1 OMQS Declared Dividends Payable
DeclaredDividendsPayable
8000 usd
CY2024Q1 OMQS Net Assets Acquired In Business Combination
NetAssetsAcquiredInBusinessCombination
1284000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
916000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
938000 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10688340 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7749870 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2979067000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3389317000 shares
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_znhdOUe7Qj3c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zk2jBiWN9tGl">Reclassifications and Comparability</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain revenue and cost of goods sold amounts in the financial statements of the prior period have been reclassified to be presented on a net basis rather than a gross to conform to the current period’s presentation for comparative purposes. The total amount reclassified from cost of goods sold to revenue, as a reduction, was $<span id="xdx_90B_eus-gaap--CostOfGoodsAndServicesSold_pn3n3_c20240101__20240331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHvrgj2n7V43" title="Costs of goods sold"><span id="xdx_902_eus-gaap--Revenues_pn3n3_c20240101__20240331__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zPAwVr0OhXt9" title="Revenues">225</span></span> thousand. This had no effect on total assets or net income.</span></p>
CY2024Q1 OMQS Working Capital Deficit
WorkingCapitalDeficit
46400000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116000000 usd
CY2024Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
45000000 usd
CY2024Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.05 pure
CY2023Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2500000 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
424000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
457000 usd
CY2024Q1 us-gaap Other Inventory In Transit
OtherInventoryInTransit
608000 usd
CY2023Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
737000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4644000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4834000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
5676000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
6028000 usd
CY2024Q1 us-gaap Other Notes Payable
OtherNotesPayable
10843000 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
10461000 usd
CY2024Q1 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
9451000 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
10196000 usd
CY2024Q1 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
1392000 usd
CY2023Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
265000 usd
CY2021Q3 us-gaap Loans Payable
LoansPayable
500000
CY2021Q3 us-gaap Loans Payable
LoansPayable
155000 usd
CY2021Q3 us-gaap Debt Instrument Term
DebtInstrumentTerm
P5Y
CY2021Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.075 pure
CY2024Q1 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
803000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
803000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
189000 usd
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
182000 usd
CY2024Q1 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
2057000 usd
CY2023Q4 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
2573000 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
3049000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
3558000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2430000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3106000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
619000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
452000 usd
CY2023Q4 us-gaap Deferred Income
DeferredIncome
2275000 usd
CY2022Q4 us-gaap Deferred Income
DeferredIncome
1393000 usd
CY2024Q1 us-gaap Deferred Income Revenue Recognized
DeferredIncomeRevenueRecognized
1352000 usd
CY2023Q1 us-gaap Deferred Income Revenue Recognized
DeferredIncomeRevenueRecognized
945000 usd
CY2024Q1 us-gaap Deferred Income Addition
DeferredIncomeAddition
803000 usd
CY2023Q1 us-gaap Deferred Income Addition
DeferredIncomeAddition
1827000 usd
CY2024Q1 us-gaap Deferred Income
DeferredIncome
1726000 usd
CY2023Q1 us-gaap Deferred Income
DeferredIncome
2275000 usd
CY2024Q1 us-gaap Other Income
OtherIncome
1700000
CY2024Q1 us-gaap Other Income
OtherIncome
609000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001493152-24-019872-index-headers.html Edgar Link pending
0001493152-24-019872-index.html Edgar Link pending
0001493152-24-019872.txt Edgar Link pending
0001493152-24-019872-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
omqs-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
omqs-20240331_cal.xml Edgar Link unprocessable
omqs-20240331_def.xml Edgar Link unprocessable
omqs-20240331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
Show.js Edgar Link pending
omqs-20240331_lab.xml Edgar Link unprocessable